We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

By LabMedica International staff writers
Posted on 05 Aug 2025

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. More...

However, IMS is hindered by relatively low spatial resolution and a lack of cellular morphological detail—both of which are crucial for accurately interpreting molecular profiles within the structural context of tissue.

Conventional workflows also rely on labor-intensive chemical staining and complex image registration, which consume time and compromise tissue integrity. Now, a novel diffusion-based virtual staining approach can transform low-resolution IMS data into high-resolution histological images, improving the clarity of tissue structure without sacrificing the original sample.

The artificial intelligence (AI)-based technique developed by an international team of researchers from the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), Vanderbilt University (Nashville, TN, USA) and Delft University of Technology (TU Delft, Delft, Netherlands) uses a diffusion-based generative model to virtually stain label-free IMS images. This model digitally produces images that closely resemble traditional histochemical staining—particularly Periodic Acid-Schiff (PAS) staining, which highlights polysaccharides, glycoproteins, and mucins—despite the original IMS data having pixel sizes nearly ten times larger than those of optical microscopy.

By optimizing the noise sampling process during AI inference, the researchers enhanced the reliability and consistency of the virtual staining. The method allows the digital transformation of IMS data into high-resolution brightfield microscopy images, eliminating the need for chemical staining and preserving tissue samples for further molecular analysis.

The research team tested the solution in blind evaluations on human kidney tissues, where the virtually stained images successfully enabled pathologists to identify critical renal structures and disease features with accuracy comparable to conventional stained images. The results, published in Nature Communications, show that the technique significantly improves the interpretability of IMS data and holds potential for widespread clinical and research applications.

By virtually introducing microscopic-level histological detail, the method supports IMS-driven molecular histology while streamlining workflows. The researchers anticipate that their AI-driven approach will open new possibilities in spatial biology and clinical diagnostics and plan to expand its use across other tissue types and staining modalities.

“This diffusion-based approach dramatically enhances the interpretability of mass spectrometry images. It virtually introduces microscopic-level histological detail, bridging the gap between molecular specificity and cellular morphology, all without chemically staining the tissue,” said Professor Aydogan Ozcan, corresponding author at UCLA.

Related Links:
UCLA 
Vanderbilt University
TU Delft


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.